Previous Article | Next Article 
Journal of Virology, June 2003, p. 6493-6506, Vol. 77, No. 11
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.11.6493-6506.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Cellular Gene Expression Survey of Vaccinia Virus Infection of Human HeLa Cells
Susana Guerra,1 Luis A. López-Fernández,2 Alberto Pascual-Montano,3 Manuel Muñoz,2 Keith Harshman,2,
and Mariano Esteban1,2,3*
Department of Molecular and Cellular Biology,1
Department of Immunology and Oncology,2
Biocomputing Unit, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Campus Universidad Autónoma, 28049 Madrid, Spain3
Received 3 February 2003/
Accepted 10 March 2003

ABSTRACT
Vaccinia virus (VV) is a cytocidal virus that causes major changes
in host cell machinery shortly after infecting cells. To define
the consequences of virus infection on host gene expression,
we used microarrays of approximately 15,000 human cDNAs to examine
expression levels of mRNAs isolated at 2, 6, and 16 h postinfection
from cultures of infected HeLa cells. The majority of profiling
changes during VV infection corresponded to downregulation of
genes at 16 h postinfection. Differentially expressed genes
were clustered into seven groups to identify common regulatory
pathways, with most of them (90%) belonging to clusters 6 and
7, which represent genes whose expression was repressed after
infection. Cluster 1, however, contained 37 transcripts (2.81%)
showing a robust pattern of induction that was maintained during
the course of infection. Genes in cluster 1 included those for
Wiskott-Aldrich syndrome protein (WASP) family member WASF1,
thymosine, adenosine A2a receptor, glutamate decarboxylase 2,
CD-80 antigen, KIAA0888 protein, selenophosphate synthetase,
pericentrin, and attractin as well as several expressed sequence
tags. We analyzed in more detail the fate of WASP protein in
VV-infected cells, because a related family member, N-WASP,
is involved in viral motility. WASP protein accumulated in the
course of infection; its increase required viral DNA replication
and de novo protein synthesis, and it localized in cytoplasmic
structures distinct from uninfected cells. This study is the
first quantitative analysis of host gene expression following
VV infection of cultured human cells, demonstrating global changes
in the expression profile, and identifies upregulated genes
with potential roles in the virus replication cycle.

INTRODUCTION
Vaccinia virus (VV) is a member of the
Poxviridae family, a
group of large, double-stranded DNA viruses that reproduce exclusively
in the cytoplasm of the infected host cell (
28). The VV genome
is subdivided into three temporally expressed classes, termed
early, intermediate, and late genes, which encode over 200 proteins,
including most of the enzymes and factors required for transcription,
genome replication, and virion assembly (
28). Immediately after
infection, early VV genes are transcribed, but the first steps
of viral DNA replication are required to transcribe late and
intermediate genes (
44). The genomes of a number of poxviruses
have been sequenced and found to contain virulence genes (
20,
24;
www.poxviruses.org).
Poxvirus infection induces a number of changes in cell function, metabolism, and cellular morphology (7). The cytopathic effect observed early after vaccinia virus infection is linked to a strong rearrangement of the cell cytoskeleton (2, 18, 31). Moreover, actin fibers are actively mobilized by nascent viral particles to form tails that are induced by intracellular envelope virus particles (10, 35). In addition, cell motility is also modified after infection (36).
Vaccinia virus infection also interferes with multiple steps in host gene expression. First, VV induces an immediate and rapid inhibition of HeLa RNA synthesis and processing (5, 30). In addition, virus-induced degradation of actin and tubulin mRNAs has been well documented in early reports (33). Concurrent with the degradation of cellular mRNA, the virus proceeds in orderly temporal expression of its own genetic information (33). Finally, host translation is drastically impaired, while viral protein synthesis takes place at maximal efficiency (3, 4).
Although many aspects of the biology of this virus have been described, little is known of its impact on host gene expression. The recent development of high-density cDNA microarrays allows simultaneous expression profiling of thousand of genes and represents a powerful approach with which to study the impact of viral infections on gene expression (6, 9, 15, 21, 29, 32, 43, 45). To obtain a more comprehensive view of the global effects of VV infection on human cells at the mRNA level, we performed cDNA microarray analysis of mRNAs obtained from VV-infected HeLa cells at various times postinfection and evaluated about 15,000 human cDNAs. We identified several mRNAs from a variety of cellular mechanisms whose levels were altered by VV infection. Genes involved in known cellular pathways and expressed sequence tags (ESTs) were defined as being differentially regulated by VV infection.
(Part of this work was presented at the XIVth International Poxvirus and Iridovirus Meeting, 20-25 September 2002, Lake Placid, N.Y.)

MATERIALS AND METHODS
Cells, viruses, and infection conditions.
HeLa cells (ATCC) were cultured in Dulbecco's medium supplemented
with 10% newborn bovine serum and antibiotics. VV wild-type,
Western Reserve strain (WR), was grown in spinner HeLa cells
and purified by banding on sucrose gradients as described previously
(
11) and titrated in monkey BSC-40 cells. All infections were
performed at a multiplicity of infection of 5 PFU/cell with
VV.
Microarray fabrication.
To generate cDNA arrays, we used the Research Genetics 40K clone human cDNA library sequence verified (http://www.resgen.com/products/SVHcDNA.php3). Forty plates containing 15,360 clones (most of known genes) were selected and grown in Luria-Bertani (LB) plus 7.5% glycerol medium (overnight, 37°C). PCRs were performed with 3 µl of each bacterial culture as the template and 5 U of Gibco Taq polymerase (Invitrogen) in the following buffer: 20 mM Tris-HCl (pH 9.0), 8.5 mM NaCl, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.4 mM deoxynucleoside triphosphate mix, 0.5 µM forward primer (5'-CTG CAA GGC GAT TAA GTT GGG TAA C-3'), and 0.5 µM reverse primer (5'-GTG AGC GGA TAA CAA TTT CAC ACA GGA AAC AGC-3'). Amplification was performed in the following conditions: 1 min of initial denaturation, 40 cycles of 30 s at 94°C, 45 s at 60°C, and 4 min at 72°C, and a final extension of 10 min at 72°C. cDNAs were confirmed with MultiScreen PCR 96-well (Millipore) and confirmed by agarose gel. Finally, PCR products were reformatted to 384-well plates, dried, and resuspended in 50% dimethyl sulfoxide. Printing was performed on CMT-GAPS II slides (Corning) with a Total Array System (BioRobotics) at 22°C and 40 to 45% relative humidity.
Microarray hybridization.
Total RNA from VV-infected (5 PFU/cell) or mock-infected HeLa cells cultured in 10-cm plates was isolated with RNAwiz (Ambion) following the manufacturer's instructions. Each RNA (40 µg) was labeled with dUTP-indodicarbocyanine (Cy5) or dUTP-indocarbocyanine (Cy3) (Pharmacia-Biotech) by direct labeling during the reverse transcription. Mock-infected sample was labeled with Cy3, and the infected sample was labeled with Cy5. This combination was changed in one experiment (mock/Cy5 and VV-infected/Cy3) to abolish differences in labeling and hybridization due to the specific characteristics of each Cy-labeled dUTP. Briefly, a mixture containing 40 µg of RNA, 150 pmol of oligo(dT)20,, 0.5 mM each dATP, dGTP, and dCTP, 0.1 mM dTTP, 0.05 mM Cy3/Cy5-dUTP, 1x first-strand reaction buffer (Invitrogen), and 10 mM dithiothreitol in a volume of 38 µl was heated (65°C, 5 min) and preincubated (42°C, 5 min), after which 400 U of SuperScript II (Invitrogen) and 40 U of RNase Inhibitor (Roche) were added and the mixture was incubated (42°C, 2.5 h).
The reaction was terminated with EDTA, and the starting RNA template was removed by adding 2 µl of 10 N NaOH, followed by incubation (65°C, 20 min). The reaction was then neutralized by adding 4 µl of 5 M acetic acid. Cy5 and Cy3 probes were mixed, and unincorporated dye was removed by isopropanol precipitation. Probes were resuspended in deionized water, and blocking reagents were added to increase specificity: poly(A) (20 µg; Sigma), tRNA (20 µg; Sigma), and human Cot-1 DNA (20 µg; Invitrogen). While the probes were drying in a Speed-Vac, microarray slides were prehybridized in 6x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.5% sodium dodecyl sulfate (SDS)-1% bovine serum albumin (42°C, 1 h). Slides were finally rinsed five times with water and dried by centrifugation (563 x g, 1 min). Probes were resuspended in 40 µl of hybridization buffer (50% formamide, 6x SSC, 0.5% SDS, 5x Denhardt's solution) and incubated with slides (42°C, 16 h) in hybridization chambers (Array-It) in a water bath in the dark. After incubation, slides were washed twice in 0.1x SSC-0.1% SDS for 5 min each and three times in 0.1x SSC for 5 min each. Finally, the slides were dried by centrifugation as before and scanned on a ScanArray 4000 (Packard Biosciences) with ScanArray 3.1 software.
Images from Cy5 and Cy3 were equilibrated, and spots were quantified with QuantArray 3.0 software (Packard Biosciences). Raw data were normalized based on the signal of genes that did not undergo variation after infection, as confirmed by Northern blot (genes APEXL2 and FLJ20643). Data from a single hybridization were viewed as log2-ratio (Cy3/Cy5) in which significant variations from 1 (no change) were indicative of increased (>2) or decreased (<-2) levels of gene expression relative to the mock-infected sample. The data shown were obtained from three independent experiments. Experiments 1 and 2 corresponded to mRNA obtained at 2, 6, and 16 h postinfection, and experiment 3 corresponded to mRNA obtained at 6 and 16 h postinfection.
Gene expression analysis.
All samples were prepared from HeLa cells grown in monolayers and infected with sucrose-purified VV. Hybridization was performed in triplicate, and only those genes whose log2-ratio values were consistently repeated in all the replicates were included in the analysis. For this purpose, we removed inconsistent replicates with quite restrictive criteria based on maximum distance to the median value: for each replicated gene, we calculated the log2-ratio median and removed those values that were beyond 1 from the median value. In this way, we assured the consistency of the resulting data set.
A variation filter was then used to eliminate genes that did not change significantly across samples (flat patterns). In this case, genes that did not show an abundance ratio of 2.0 in at least one experimental condition were eliminated from the data set. The resulting data set after the different preprocessing steps was composed of 1,318 genes. The length of each resulting expression vector was normalized to 1 previous to clustering.
To classify gene expression profiles into groups according to their behavior patterns, cluster analysis was carried out by self-organizing maps (22, 42). Since the experimental data contain only three conditions (2 h, 6 h, and 16 h), a simple three-dimensional scatter plot would be sufficient for visual clustering of the data set. Nonetheless, as visual inspection might fail to detect subtle variation patterns hidden in the data set, a more sophisticated technique (self-organizing maps) was used in this study for clustering purposes. Self-organizing maps is a powerful technique that allows nonlinear projection of the original data onto a two-dimensional grid so that the resulting map is ordered according to certain data features, allowing a simple, intuitive visualization of the clustering structure. To calculate the self-organizing maps, we used the Engene software package (www.engene.cnb.uam.es) (14).
The expression patterns were projected onto a 10 by 5 hexagonal grid with the self-organizing maps algorithm. Each node in the map is an expression profile representing a subset of the expression patterns under analysis. The self-organizing maps algorithm was trained in two phases, a global ordering and a fine adjustment (22). In the first stage, the algorithm was iterated 100,000 times, linearly decreasing the learning rate from 0.3 to 0. The neighborhood radius was also linearly decreased from 5 to 1. In the second fine-adjustment phase, the algorithm was iterated 500,000 times, varying the learning rate linearly from 0.1 to 0 and decreasing the neighborhood radius linearly from 2 to 1 (22).
Northern blot.
Total RNA (20 µg) was fractionated by electrophoresis through 1% agarose gels containing formaldehyde and blotted in 20x SSC onto Nytran nylon membranes (Schleicher and Schuell). cDNA fragments were labeled with [32P]dCTP with the ReadyPrime system (Amersham). Hybridization was performed in Church buffer (0.2 M sodium phosphate [pH 7], 1 mM EDTA, 1% bovine serum albumin, 10% SDS) at 68°C overnight. Membranes were washed twice in 2x SSC-0.1x SDS (65°C, 1 h) and twice in 0.1x SSC-0.1x SDS (65°C, 1 h) and exposed for 12 h to a Storm phosphorimager (Molecular Dynamics, Sunnyvale, Calif.).
Quantitative real-time RT-PCR.
One microgram of RNA was reverse transcribed according to the Superscript first-strand synthesis system for reverse transcription-PCR (RT-PCR) protocol (Invitrogen). A 1:40 dilution of the RT reaction mixture was used in the quantitative PCR. Primers, probe set, and protocols used for the amplification of PCNT2, WASF1, and IL-6ST were performed with the instructions of the manufacturer (Assay-on-Demand of Applied Biosystems). Gene expression quantification with Assay-on-Demand is optimized to work with TaqMan Universal PCR MasterMix, No AmpErase UNG. We used the human housekeeping gene hypoxanthine ribosyltransferase (HPRT) for internal calibration. The thermal cycler conditions were 2 min at 50°C, 10 min at 95°C, and then 40 cycles of 15 s at 95°C followed by 1 min at 60°C. The amplification of cDNA was carried out in a 96-well reaction plate. All the samples were assayed in duplicate. The threshold cycle (Ct) values were used to plot a standard curve in which Ct decreased in linear proportion of the log of the template copy number. The correlation values of standard curves were always more than 99%.
Western blot.
HeLa cells were infected at a multiplicity of infection of 5 PFU/cell with VV, collected, and lysed at 2, 6, and 16 h postinfection in lysis buffer (50 mM Tris-HCl [pH 8.0], 0.5 M NaCl, 10% NP-40, 1% SDS) maintained on ice for 5 min. Equal amounts of protein lysates were separated by SDS-polyacrylamide gel electrophoresis on 14% or 8% gels, transferred to nitrocellulose membranes, and reacted with primary antiactin (Sigma), antitubulin (Sigma), and anti-Wiskott-Aldrich syndrome (WAS) family member antibodies (kindly provided by Antonio Bernad) and with secondary antibodies (mouse and rabbit immunoglobulin-peroxidase conjugates). Protein expression was detected with ECL Western blotting reagents (Amersham).
Immunofluorescence.
HeLa cells cultured on coverslips were infected at 5 PFU/cell with VV. At 2, 6, and 16 h postinfection, cells were washed with phosphate-buffered saline, fixed with 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100 in phosphate-buffered saline (room temperature, 10 min). Cells were incubated with antibodies to the A27L viral protein (monoclonal antibody C3
14k) together with anti-WAS family member antibody and the DNA-staining reagent ToPro (Molecular Probes). Images were obtained with a Bio-Rad Radiance 2100 confocal laser microscope.

RESULTS
Analysis of clusters.
We used human cDNA microarrays to study the global transcriptional
response of HeLa cells infected with VV (WR strain). We chose
HeLa cells because they are highly susceptible to VV infection
and many fundamental studies of VV biology have been performed
with this cell line. To study the cellular transcriptional response
during VV infection, we compared the relative abundance of a
specific mRNA in infected cells with the same specific mRNA
from mock-infected cells in cDNA microarrays. The gene expression
clusters of the resulting 1,318 genes that passed the filtering
conditions are depicted in Fig.
1. In global terms, expression
of most of these genes (90%) was downregulated at 6 to 16 h
after VV infection. However, a more detailed analysis of profiles
led us to group the genes into seven main clusters according
to their behavior over the three time points of VV infection.
These clusters seem to represent specific regulation patterns,
and the average profiles for each of the clusters depicted are
shown in Fig.
2.
Clusters 1 to 3 correspond roughly to three different kinetics
of gene activation, whereas clusters 4 to 7 show different repression
kinetics. Cluster 1 contained 37 transcripts (2.81%) that were
upregulated during the infection; it is the only cluster that
showed a generalized induction pattern maintained from 2 to
16 h postinfection. The members of cluster 1 are detailed in
Table
1. Cluster 2 contained 24 transcripts (1.82%), including
genes whose induction was maintained from 2 to 6 h postinfection
and returned to basal levels at 16 h postinfection; cluster
2 members are represented in Table
2. Cluster 3 contained five
transcripts (0.36%) with an upregulation pattern at 2 h postinfection
that returned to basal levels at 6 h postinfection. Cluster
4 contained one transcript, gamma interferon-inducible protein
16, which was slightly upregulated at 6 h postinfection. Cluster
5 contained 71 transcripts (5.39%) that were upregulated at
2 h postinfection and downregulated at 6 and 16 h postinfection.
Cluster 6 was the largest group, containing 828 transcripts
(62.82%), which were completely repressed at 6 and 16 h postinfection.
This cluster included genes involved in transcription, translation,
subcellular trafficking, apoptosis, metabolic pathways, and
other vital cell processes. Cluster 7 contained 352 transcripts
(26.71%), with a pattern of decreasing repression at 2, 6, and
16 h postinfection (Table
3).
Target verification by Northern blot analysis and real-time RT-PCR of representative genes.
Selected genes with different post-VV infection expression patterns,
as derived from microarray results, were chosen for target verification
by Northern blot analysis. Total RNA was purified from uninfected
or VV-infected cells at 2, 6, and 16 h postinfection, fractionated
by gel electrophoresis, blotted, and probed with
32P-labeled
PCR products that were spotted on the microarray. The RNA preparation
used for this analysis was the same as that used in the microarray.
The amount of RNA spotted on the blot was normalized based on
rRNA content. In all cases, the Northern blot confirmed the
microarray results (Fig.
3). Whereas the expression pattern
of the elongation factor gene (EF) was still detected at 2 h
postinfection, strong inhibition was observed at 6 and 16 h
postinfection compared to the control sample. A peak of histone
L gene H2AFL mRNA expression was reached at 2 h postinfection;
a similar expression pattern was shown by the histone H2FB gene.
A constitutive expression pattern of the apurinic/apyridiminic
endonuclease gene (APEXL2) and the EST FLJ20643 was observed
in the presence and absence of VV. EST N34895 expression was
detected only following infection. Strong upregulation of WASP
expression was also observed during VV infection. The expression
of the VV E3L early gene was analyzed as a control for virus
infection.
As an alternative to the Northern blot data, real-time RT-PCR
was used to verify the transcriptional change in selected genes,
as detected by microarray. Three genes were chosen for analysis:
two were upregulated (PCNT2 and WASP) and one was not altered
(IL-6ST). HPRT was used as an internal control. As shown in
Table
4, the RT-PCR data confirmed the microarray results, showing
the same relative regulation of transcription of the selected
genes and hence validating the Northern and the microarray findings.
The absolute values are not identical between the microarray
and RT-PCR data, but this is probably due to the intrinsic differences
between the techniques.
Target verification by Western blot and immunofluorescence of representative cellular proteins.
To correlate changes in transcription with protein levels, we
studied the effect of infection on some cytoskeletal components
by analyzing actin and tubulin expression levels by immunoblot.
Although actin gene expression was downregulated at 6 h postinfection
in microarray analysis (see Table
3), the protein was present
in equal amounts in mock- and VV-infected cells at 2, 6, and
16 h postinfection (Fig.
4A). This is probably due to the high
stability of actin. After virus infection, the microarray data
indicated that tubulin expression was downregulated (Table
3),
and this was confirmed by Western blot analysis of tubulin protein
levels (Fig.
4A). Tubulin degradation was quantified by densitometry,
which showed that tubulin expression decreased 10-fold at 16
h postinfection compared to mock-infected cells (Fig.
4B). These
data were confirmed by immunofluorescence staining with fluorescein-labeled
phalloidin and antitubulin antibodies (Fig.
4C and D). These
findings show that the correlation between levels of mRNAs and
protein depends on the stability of a given protein.
Since N-WASP has been shown to play an important role in the
actin-mediated motility of VV as a mechanism to viral spread
between cells (
12-
13,
19,
34), we next focused our work on the
WASP protein family member WASF1, which was upregulated more
than twofold in VV-infected cells compared to uninfected control
cells (Table
1). In agreement with the Northern, microarray,
and real-time RT-PCR data, a clear increase in WASP protein
levels was evident in VV-infected cells by Western blot analysis
(Fig.
5). The WASP protein signal increased early in infection
and reached a maximal level at 16 h postinfection. At this time,
the amount of WASP in VV-infected cells was threefold higher
than in control cells. The increase in WASP protein required
viral DNA replication, as observed by infecting cells in the
presence of adenosine arabinosidede, an inhibitor of VV DNA
synthesis. Moreover, the increase in the WASP protein level
required de novo protein synthesis, because its accumulation
was prevented by cycloheximide treatment. This result discards
the possibility that VV infection might be increasing the WASP
protein level by enhancing protein stability.
Given the known involvement of N-WASP in VV-mediated cytoskeletal
changes (
19,
34), we next analyzed the subcellular localization
of WASP. To this end, we performed comparative immunofluorescence
analysis of intracellular WASP distribution between VV-infected
cells at 6 and 16 h postinfection and uninfected cells. While
in uninfected cells WASP appeared in defined regions of the
cytoplasm, with time of VV infection, there was a clear increase
in WASP protein intensity, with a subcellular distribution distinct
from that of uninfected cells (Fig.
6). The subcellular distribution
of WASP was compared with that of the VV membrane protein p14
(A27L gene). At late times postinfection, p14 localized as a
soluble component but mostly as part of intracellular mature
virus, giving a single-dot appearance. Image merging indicated
some colocalization of WASP with p14 (Fig.
6).
To analyze further the intracellular localization of WASP in
infected cells, we used antibodies to the wheat germ antigen,
a specific marker for Golgi structures. In uninfected cells,
WASP protein was present mainly in the Golgi region, whereas
in infected cells, WASP protein localized in cytoplasmic structures
that lacked Golgi organization (Fig.
7). Since a significant
fraction of mature virions colocalized with WASP protein (compare
the dots in Fig.
6 and
7, merge panel), these observations suggest
a possible functional and/or biochemical interaction between
VV proteins and WASP.

DISCUSSION
With cDNA microarrays, we analyzed the expression of approximately
15,000 human cDNAs during VV infection of HeLa cells and identified
genes that are differentially expressed and belong to a variety
of cellular pathways. This work describes for the first time
the global change in the cellular mRNA content in response to
a poxvirus infection. Our results show that VV infection has
a major impact on the expression pattern of specific cellular
genes. We performed our analysis at 2, 6, and 16 h postinfection
and observed drastic changes in the amount of mRNA in VV-infected
compared to uninfected cells. This led us to analyze the temporal
behavior of host genes over infection that could bring new clues
on the role that these genes play in the context of the VV-infected
cell.
The majority (90%) of the differentially expressed genes showed expression patterns characterized by diminished levels compared to mock-infected controls. Expression of host genes that govern vital cell processes such as replication, transcription, and translation was downregulated during the course of infection. The expression of other genes involved in apoptosis or the proteasome-ubiquitin degradation pathway was also repressed. These findings support the notion that cytocidal viruses often lead to profound changes in host gene expression (6, 30). Notably, our results indicate that VV infection upregulates expression of a discrete number of genes with known functions and several ESTs with unknown functions, not described previously as being upregulated by other viruses (9, 15, 29).
The global reduction in mRNA content observed in VV-infected cells might be due to a general repression of host transcription or increased degradation rates of cellular mRNAs. At this time we cannot distinguish between these two possibilities. However, since VV infection affects both the synthesis and the stability of cellular mRNAs, the data obtained here probably reflect the interference of VV with multiple steps in host gene expression (5, 30, 33).
More interesting is the fact that VV infection increased the level of some specific host mRNAs. This could be due to a general response of the cell to stress situations or may be a more specific response of the cell to poxvirus infection. Notably, some of these genes encode structural components of the cell, such as Golgi resident protein 60 (GCP-60), claudin 3, and pericentrin. Although the roles that these proteins play in the cell are well established (1, 38-39) the biological meaning of their upregulation by VV is not immediately clear. VV could benefit from increased expression of host genes encoding structural components of the cell, since production of progeny virus requires the integrity of some cellular structures. For instance, formation of extracellular envelope virus requires the Golgi apparatus for intracellular mature virus acquisition of an extra double membrane (17).
Another gene that underwent upregulation after VV infection was EST N34895, a homolog of coxsackievirus and adenovirus receptors. One can speculate that N34895 might be involved in some step of VV entry, although further experiments will be necessary to test this possibility.
Among the genes upregulated by VV infection, perhaps the function of WASP has the most obvious biological meaning in VV-infected cells. VV infection triggers transduction pathways, and WASP is an effector molecule involved in signal transmission from tyrosine kinase receptors and small GTPases to the actin cytoskeleton (8, 26, 40-41). N-WASP, a related member of the WASP family, is implicated in the actin-mediated motility of VV as a mechanism to spread virus between cells (12-13, 19, 34). The molecular mechanism of this process involves the Src family kinase-dependent tyrosine phosphorylation of tyrosine residues 112 and 132 of viral transmembrane protein A36R, the tail nucleator (19, 27, 37). These posttranslational modifications regulate a direct recruitment of Nck, Grb2, WAS-interacting protein, and N-WASP to the virus particle and actin polymerization via the Arp2/3 complex (16, 23, 25).
We observed a clear upregulation of WASP expression during VV infection, with a correlation between WASP mRNA and protein levels. The increase in WASP protein required viral DNA replication, shown by infecting cells in the presence of adenosine arabinoside, an inhibitor of VV DNA synthesis. Moreover, the increase in WASP protein level required de novo protein synthesis because it was prevented by cycloheximide treatment. Although the biological relevance of this upregulation remains to be established, it can be speculated in view of the functions assigned to N-WASP that WASP protein might be involved in some step of virus budding or maturation by regulating the organization of actin-containing cytoskeleton, thus facilitating the spread of the virus. Our preliminary observations in tissue-specific knockouts of WAS in mice suggest a role for WAS family members in the release of VV from infected cells (unpublished data).
In conclusion, this study is the first quantitative analysis of host cell gene expression following VV infection in cultured human cells. The results identify a number of cellular genes whose expression levels are markedly modified by VV infection and suggest potential roles as regulators of viral infection. We demonstrate the usefulness of microarray technology in the study of poxvirus-host interactions. Additional studies with a variety of virus strains, mutants, cell lines, and in vivo animal model systems will be required to obtain a comprehensive pattern of host cell gene expression and biological effects following poxvirus infection. The impact of VV on host gene expression is important considering the potential application of VV as a recombinant vaccine and the threat of bioterrorism with variola virus and related poxviruses.

ACKNOWLEDGMENTS
We are indebted to to R. Conde for helpful quantitative PCR
assistance, to A. Bernad for kindly providing the WASP antibody,
to J. M. Fernández and J. C. Oliveros for bioinformatic
assistance, to I. Ventoso, S. Masciotra, and C. Mark for critical
review of the manuscript, and to V. Jiménez for expert
technical assistance.
This work was supported by the Spanish Ministry of Science and Technology BIO2000-0340P4 and BIO2001-2269 (to M.E.). The Department of Immunology and Oncology was founded and is supported by the Spanish Council (CSIC) and Pharmacia.

FOOTNOTES
* Corresponding author. Mailing address: Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Campus Universidad Autónoma, 28049 Madrid, Spain. Phone: (34) 91/585-4503. Fax: (34) 91/585-4506. E-mail:
mesteban{at}cnb.uam.es.

Present address: Center for Integrative Genomics, Université de Lausanne, Lausanne, Switzerland. 

REFERENCES
- 1 Adams, C., P. Diadori, L. Schoenroth, and M. Fritzler. 2000. Autoantibodies in childhood post-varicella acute cerebellar ataxia. Can. J. Neurol. Sci. 4:316-320.
- 2 Bablanian, R., B. Baxt, J. A. Sonnabend, and M. Esteban. 1978. Studies on the mechanism of vaccinia virus cytopathic effects. II. Early cell rounding is associated with virus polypeptide synthesis. J. Gen. Virol. 39:403-413.[Abstract/Free Full Text]
- 3 Bablanian, R., G. Coppola, S. Scribani, and M. Esteban. 1981. Inhibition of protein synthesis by vaccinia virus. IV. The role of low-molecular-weight viral RNA in the inhibition of protein synthesis. Virology 112:13-24.[CrossRef][Medline]
- 4 Bablanian, R., M. Esteban, B. Bax, and J. A. Sonnabend. 1978. Studies on the mechanisms of vaccinia virus cytopathic effects. I. Inhibition of protein synthesis in infected cells is associated with virus-induced RNA synthesis. J. Gen. Virol. 39:391-402.[Abstract/Free Full Text]
- 5 Becker, Y., and W. K. Joklik. 1964. Messenger RNA in cells infected with vaccinia virus. Proc. Natl. Acad. Sci. USA 51:577-584.[Free Full Text]
- 6 Bolt, G., K. Berg, and M. Blixenkrone-Moller. 2002. Measles virus-induced modulation of host-cell gene expression. J. Gen. Virol. 83:1157-1165.[Abstract/Free Full Text]
- 7 Buller, R. M. L., and G. J. Palumbo. 1991. Poxvirus pathogenesis. Microbiol. Rev. 55:80-122.[Abstract/Free Full Text]
- 8 Caron, E. 2002. Regulation of Wiskott-Aldrich syndrome protein and related molecules. Curr. Opin. Cell Biol. 14:82-87.[CrossRef][Medline]
- 9 Chang, Y. E., and L. A. Laimins. 2000. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional target of human papillomavirus type 31. J. Virol. 74:4174-4182.[Abstract/Free Full Text]
- 10 Cudmore, S., P. Cossart, G. Griffiths, and M. Way. 1995. Actin-based motility of vaccinia virus. Nature 378:636-638.[CrossRef][Medline]
- 11 Esteban, M. 1984. Defective vaccinia virus particles in interferon-treated infected cells. Virology l33:220-227.
- 12 Frischknecht, F., S. Cudmore, V. Moreau, I. Reckmann, S. Rottger, and M. Way. 2001. Tyrosine phosphorylation is required for actin based motility of vaccinia virus but not for Listeria or Shigella. Curr. Biol. 9:89-92.
- 13 Frischknecht, F., V. Moreau, S. Rottger, I. Reckmann, C. Superti-Furga, and M. Way. 1999. Actin based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 404:1007-1011.
- 14 García de la Nava, J., Franco D. Santaella, Cuenca J. Alba, J. M. Carazo, O. Trelles, and A. Pascual-Montano. 2002. Engene: the processing and exploratory analysis of gene expression. Bioinformatics 19:657-658.
- 15 Geiss, G. K., R. E. Bumgarner, M. C. An, A. B. Agy, A. B. van't Wout, E. Hammersmark, V. S. Carter, D. Upchurch, J. I. Mullins, and M. G. Katze. 2001. Large-scale monitoring of host gene expression during HIV-1 infection with cDNA microarrays. Virology 266:8-16.
- 16 Higgs, H. N., and T. D. Pollard. 2001. Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annu. Rev. Biochem. 70:649-676.[CrossRef][Medline]
- 17 Hiller, G., and K. Weber. 1982. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J. Virol. 55:651-659.
- 18 Hiller, G., K. Weber, L. Schneider, C. Parajsz, and C. Jungwirth. 1979. Interaction of assembled progeny pox viruses with the cellular cytoskeleton. Virology 98:142-153.[CrossRef][Medline]
- 19 Hollinshead, M., G. Rodger, H. Van Eijl, M. Law, R. Hollinshead, D. J. Vaux, and G. L. Smith. 2001. Vaccinia virus utilizes microtubules for movement to the cell surface. J. Cell Biol. 154:389-402.[Abstract/Free Full Text]
- 20 Johnson, G. P., S. J. Goebel, and E. Paoletti. 1993. An update on the vaccinia virus genome. Virology 196:196., 381-401.
- 21 Jones, J., and A. M. Arvin. 2003. Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. J. Virol. 77:1268-1280.[CrossRef][Medline]
- 22 Kohonen, T. 1997. Self-organizing maps, 2nd ed. Springer-Verlag, Berlin, Germany.
- 23 Martinez-Quiles, N., R. I. M. Rohatgi, M. Medina, S. P. Saville, H. Miki, H. Yamaguchi, T. Takenawa, J. H. Hartwig, R. S. Geha, and N. Ramesh. 2001. WIP regulates N-WASP-mediated actin polymerization and filopodium formation. Nat. Cell Biol. 3:484-491.[CrossRef][Medline]
- 24 Massung, R. F., J. J. Esposito, L. Liu, J. Qi, T. R. Utterback, J. C. Knight, L. Aubin, L., T. E. Yuran, J. M. Parson, V. N. Loparev, et al. 1993. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 224:1280-1284.[CrossRef]
- 25 McKarty, J. H. 1998. The Nck SH2/SH3 adaptador protein: a regulator of multiple intracellular signal transduction events. Bioassays 20:913-921.[CrossRef][Medline]
- 26 Miki, H., K. Minura, and T. Takenawa. 1996. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream or tyrosine kinases. EMBO J. 15:5326-5335.[Medline]
- 27 Moreau, V., F. Frischknecht, I. Reckmann, G. Superti-Furga, and M. Way. 2000. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat. Cell Biol. 2:441-448.[CrossRef][Medline]
- 28 Moss, B. 2001. Poxviridae: the viruses and their replication, p. 2649-2885. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 4th ed., vol. 2. Lippincott-Raven Press, New York, N.Y.
- 29 Nees, N., J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. I. Woodworth. 2001. Papillomavirus type 16 oncogenes downregulate expression interferon-responsive genes and upregulate proliferation-associated and NF
B-responsive genes in cervical keratinocytes. J. Virol. 75:4283-4296.[Abstract/Free Full Text]
- 30 Pedley, S., and R. J. Cooper. 1984. The inhibition of HeLa cell RNA synthesis following infection with vaccinia virus. J. Gen. Virol. 65:1687-1697.[Abstract/Free Full Text]
- 31 Ploubidou, A., V. Moreau, K. Ashman, I. Reckmann, C. González, and M. Way. 2000. Vaccinia virus infection disrupts microtubule organization and centrosome function. EMBO J. 19:3932-3944.[CrossRef][Medline]
- 32 Portis, T., and R. Longnecker. 2003. Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J. Virol. 77:105-114.[Abstract/Free Full Text]
- 33 Rice, A. P., and B. E. Roberts. 1983. Vaccinia virus induces cellular mRNA degradation. J. Virol. 47:529-539.[Abstract/Free Full Text]
- 34 Rietdorf, J., A. Ploubidou, I. Reckmann, A. Holmstrom, F. Frischknecht, M. Zettl, T. Zimmermann, and M. Way. 2001. Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat. Cell Biol. 3:992-1000.[CrossRef][Medline]
- 35 Rottger, S., F. Frischknecht, I. Reckmann, G. L. Smith, and M. Way. 1999. Interactions between vaccinia virus intracellular envelope virus membrane proteins and their roles in intracellular envelope virus assembly and actin tail formation. J. Virol. 73:2863-2875.[Abstract/Free Full Text]
- 36 Sanderson, C. M., M. Way, and G. L. Smith. 1998. Virus-induced cell motility. J. Virol. 72:1235-1243.[Abstract/Free Full Text]
- 37 Scaplehorn, N., A. Holmstrom, V. Moreau, F. Frischknecht, I. Reckmann, and M. Way. 2002. Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr. Biol. 12:740-745.[CrossRef][Medline]
- 38 Sharon, H., A. Purohit, J. Doxey, and R. B. Vallee. 2000. Light intermediate chain 1 defines a functional subfraction of cytoplasmic dynein which binds to pericentrin. J. Biol. Chem. 42:32763-32768.
- 39 Sohda, M., Y. Misumi, A. Yamamoto, A. Yano, N. Nakamura, and Y. Ikehara. 2001. Identification and characterization of a novel Golgi protein, GC60, that interacts with the integral membrane protein giantin. J. Biol. Chem. 48:45298-45306.
- 40 Symons, M., J. M. Derry, B. Karlak, S. Jiang, V. Lemahieu, F. McCormick, U. Francke, and A. Abo. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase Cdc42Hs, is implicated in actin polymerization. Cell 84:723-734.[CrossRef][Medline]
- 41 Takenawa, T., and H. Miki. 2001. WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J. Cell Sci. 114:1801-1809.[Abstract]
- 42 Tamayo, P., D. Slonim, J. Mesirov, Q. Zhu, E. Dmitrovsky, E. S. Lander, and T. R. Golub. 1999. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. USA 96:2907-2912.[Abstract/Free Full Text]
- 43 Van't Wout, A. B., G. K. Lehrman, S. A. Mikheeva, G. O'Keeffe, M. G. Katze, R. E. Bumgarner, G. K. Geiss, and J. I. Mullins. 2003. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4+ T-cell lines. J. Virol. 77:1392-1402.[CrossRef][Medline]
- 44 Vos, J. C., and H. G. Stunnenberg. 1988. Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J. 7:3487-3492.[Medline]
- 45 Zhu, H., J. P. Cong, G. Mantora, T. Gineras, and T. Shenk. 1998. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:14470-14475.[Abstract/Free Full Text]
Journal of Virology, June 2003, p. 6493-6506, Vol. 77, No. 11
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.11.6493-6506.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Parrish, S., Moss, B.
(2007). Characterization of a Second Vaccinia Virus mRNA-Decapping Enzyme Conserved in Poxviruses. J. Virol.
81: 12973-12978
[Abstract]
[Full Text]
-
Hurtado, M., Lozano, J. J., Castellanos, E., Lopez-Fernandez, L. A, Harshman, K., Martinez-A, C., Ortiz, A. R, Thomson, T. M, Paciucci, R.
(2007). Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells. Gut
56: 1266-1274
[Abstract]
[Full Text]
-
Guerra, S., Najera, J. L., Gonzalez, J. M., Lopez-Fernandez, L. A., Climent, N., Gatell, J. M., Gallart, T., Esteban, M.
(2007). Distinct Gene Expression Profiling after Infection of Immature Human Monocyte-Derived Dendritic Cells by the Attenuated Poxvirus Vectors MVA and NYVAC. J. Virol.
81: 8707-8721
[Abstract]
[Full Text]
-
Langland, J. O., Kash, J. C., Carter, V., Thomas, M. J., Katze, M. G., Jacobs, B. L.
(2006). Suppression of Proinflammatory Signal Transduction and Gene Expression by the Dual Nucleic Acid Binding Domains of the Vaccinia Virus E3L Proteins. J. Virol.
80: 10083-10095
[Abstract]
[Full Text]
-
Guerra, S., Lopez-Fernandez, L. A., Garcia, M. A., Zaballos, A., Esteban, M.
(2006). Human Gene Profiling in Response to the Active Protein Kinase, Interferon-induced Serine/threonine Protein Kinase (PKR), in Infected Cells: INVOLVEMENT OF THE TRANSCRIPTION FACTOR ATF-3 IN PKR-INDUCED APOPTOSIS. J. Biol. Chem.
281: 18734-18745
[Abstract]
[Full Text]
-
Hoover, S. E., Cohrs, R. J., Rangel, Z. G., Gilden, D. H., Munson, P., Cohen, J. I.
(2006). Downregulation of Varicella-Zoster Virus (VZV) Immediate-Early ORF62 Transcription by VZV ORF63 Correlates with Virus Replication In Vitro and with Latency. J. Virol.
80: 3459-3468
[Abstract]
[Full Text]
-
Thilo, C., Berglund, P., Applequist, S. E., Yewdell, J. W., Ljunggren, H.-G., Achour, A.
(2006). Dissection of the Interaction of the Human Cytomegalovirus-derived US2 Protein with Major Histocompatibility Complex Class I Molecules: PROMINENT ROLE OF A SINGLE ARGININE RESIDUE IN HUMAN LEUKOCYTE ANTIGEN-A2. J. Biol. Chem.
281: 8950-8957
[Abstract]
[Full Text]
-
Guerra, S., Lopez-Fernandez, L. A., Pascual-Montano, A., Najera, J. L., Zaballos, A., Esteban, M.
(2006). Host Response to the Attenuated Poxvirus Vector NYVAC: Upregulation of Apoptotic Genes and NF-{kappa}B-Responsive Genes in Infected HeLa Cells. J. Virol.
80: 985-998
[Abstract]
[Full Text]
-
Brooks, C. R., Elliott, T., Parham, P., Khakoo, S. I.
(2006). The Inhibitory Receptor NKG2A Determines Lysis of Vaccinia Virus-Infected Autologous Targets by NK Cells. J. Immunol.
176: 1141-1147
[Abstract]
[Full Text]
-
Dowling, R. J. O., Bienzle, D.
(2005). Gene-expression changes induced by Feline immunodeficiency virus infection differ in epithelial cells and lymphocytes. J. Gen. Virol.
86: 2239-2248
[Abstract]
[Full Text]
-
Guerra, S., Aracil, M., Conde, R., Bernad, A., Esteban, M.
(2005). Wiskott-Aldrich Syndrome Protein Is Needed for Vaccinia Virus Pathogenesis. J. Virol.
79: 2133-2140
[Abstract]
[Full Text]
-
Ludwig, H., Mages, J., Staib, C., Lehmann, M. H., Lang, R., Sutter, G.
(2005). Role of Viral Factor E3L in Modified Vaccinia Virus Ankara Infection of Human HeLa Cells: Regulation of the Virus Life Cycle and Identification of Differentially Expressed Host Genes. J. Virol.
79: 2584-2596
[Abstract]
[Full Text]
-
Pontow, S. E., Heyden, N. V., Wei, S., Ratner, L.
(2004). Actin Cytoskeletal Reorganizations and Coreceptor-Mediated Activation of Rac during Human Immunodeficiency Virus-Induced Cell Fusion. J. Virol.
78: 7138-7147
[Abstract]
[Full Text]
-
Guerra, S., Lopez-Fernandez, L. A., Conde, R., Pascual-Montano, A., Harshman, K., Esteban, M.
(2004). Microarray Analysis Reveals Characteristic Changes of Host Cell Gene Expression in Response to Attenuated Modified Vaccinia Virus Ankara Infection of Human HeLa Cells. J. Virol.
78: 5820-5834
[Abstract]
[Full Text]
-
Child, S. J., Hakki, M., De Niro, K. L., Geballe, A. P.
(2004). Evasion of Cellular Antiviral Responses by Human Cytomegalovirus TRS1 and IRS1. J. Virol.
78: 197-205
[Abstract]
[Full Text]
-
Gallego-Gomez, J. C., Risco, C., Rodriguez, D., Cabezas, P., Guerra, S., Carrascosa, J. L., Esteban, M.
(2003). Differences in Virus-Induced Cell Morphology and in Virus Maturation between MVA and Other Strains (WR, Ankara, and NYCBH) of Vaccinia Virus in Infected Human Cells. J. Virol.
77: 10606-10622
[Abstract]
[Full Text]